Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study

• Published in: Human vaccines & immunotherapeutics Vol. 19; no. 2; p. 2242217
• Main Authors: Cao, Cheng, Guo, Qin, Dai, Yaping, Jiang, Junfeng, Liu, Min, Ji, Tuo, Zhou, Pengcheng, Gong, Fang
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.08.2023; Taylor & Francis Group
• Subjects: Antibodies, Neutralizing; Antibodies, Viral; Brief Report; coronavac; Coronavirus; COVID-19 - prevention & control; covid-19 vaccine; Follow-Up Studies; Humans; Immunoglobulin G; neutralizing antibodies; omicron subvariants; SARS-CoV-2; COVID-19 vaccine; neutralizing antibodies; SARS-CoV-2; CoronaVac; Omicron subvariants

The durability of antibody responses induced by the three-dose of CoronaVac vaccination, especially against SARS-CoV-2 Omicron subvariants, remains unclear. Here in our study, 160 plasma samples from 32 healthy individuals who received three doses of CoronaVac were longitudinally tracked for a perio...